SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Welcome to the POTP board, the DPP-IV company
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rareearth42 who wrote (40)11/19/2006 5:26:51 PM
From: drbio45  Read Replies (1) of 90
 
Right now Point has a market cap with a phase 3 drug in a billion dollar market with a 45 million dollar market cap on fully diluted shares.

the drug is an oral pill that reduces the toxicities of the chemo drugs it is used with and actually is synergistic with them.

The fact that the company has been put into this condition because the management waited too long to raise money is unfortunate. Management made a mistake and the funds getting out before the raise hurt the stock.

I own some but not as much as I had and I will buy more when the financing is finally done because I believe the drug works and will be big but I don't know where the stock will be by the time they raise the money.

This was certainly amateur hour.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News